Aspect Medical Systems

Today, Aspect is recognized as a pioneer and global market leader in brain monitoring, having led the way to develop proprietary technologies that directly measure these effects and ultimately improve the quality and cost effectiveness of patient care.

Aspect's premier product - Bispectral Index® (BIS®) technology -became the first clinically proven and commercially available direct measure of the effects of anesthetics and sedatives on the brain. At present an estimated 20 million patients undergo surgery with general anesthesia or deep sedation each year in the United States, and an additional 30 million in Europe and Japan. BIS technology allows medical professionals, for the first time, to reliably gauge the precise amount of drug required by each patient, resulting in better overall patient care and fewer undesirable events.

Contact Details: One Upland Road Norwood 02062 United States of America Tel: 1-617-559-7000 Fax: 1-617-559-7400 Email: bis_info@aspectms.com WWW: www.aspectmedical.com/

Recent Publications by Aspect Medical Systems:
Regulatory challenges facing closed-loop anesthetic drug infusion devices. Closed-loop anesthetic drug infusion devices show great promise for...	8th July, 2008	Aspect Medical Systems,	Clin Pharmacol Ther. 2008 Jul;84(1):166-9. Epub 2008 May 7. DOI Direct Link
A true to life simulation of electrosurgery. A laboratory simulation has been devised for use in developing and testing...	11th March, 2008	Aspect Medical Systems, Inc., Boston, MA 02464, USA.	Conf Proc IEEE Eng Med Biol Soc. 2006;1:5105-8. DOI Direct Link

BioNews Results for Aspect Medical Systems:
VisEn Announces Commercial Launch of IntegriSense Fluorescence Molecular Imaging Agent	Pharma Live:  Aug 20 2008 12:43AM Matching: aspect medical systems
VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent	Financials.com:  Aug 19 2008 10:28PM Matching: aspect medical systems
VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent	San Antonio Business Journal:  Aug 19 2008 2:14PM Matching: aspect medical systems
VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent	Columbus Business First:  Aug 19 2008 1:54PM Matching: aspect medical systems
VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent	Business Journal of Milwaukee:  Aug 19 2008 1:48PM Matching: aspect medical systems
Promote your company here: BioNewsCast - Press Release Distribution	→View more Aspect Medical Systems news.

Aspect Medical Systems Patents:
US Patent No.	Title
7418290	System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram
6236874	Electrode connector system
6032072	Method for enhancing and separating biopotential signals
6032064	Electrode array system for measuring electrophysiological signals
5813404	Electrode connector system
→View more Aspect Medical Systems patents.

Aspect Medical Systems (ASPM) Financial information Links from Barchart
ASPM Quote from from Barchart.com
ASPM Chart from from Barchart.com
ASPM Profile from from Barchart.com
ASPM Opinion from from Barchart.com
→View more Aspect Medical Systems finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 140 times since April 2007, the link to the organisation's website has been followed 26 times

Recent Search Terms used to find this page: Aspect Medical uk | .

Search for more companies in Norwood

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Aspect Medical Systems